AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36008722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemiplimab plus chemotherapy (350 mg every 3 weeks for up to 108 weeks)
Number of subjects: 466
Study 36008722 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 466
Study 36008722 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemiplimab plus chemotherapy
Number of subjects: 466
Study 35109470 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence (MediCul score)
Number of subjects: 6236
Study 35109470 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic physical activity (PA)
Number of subjects: 6236
Study 35109470 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 6236
Study 35109470 — intervention group
Group type: EXPERIMENTAL
Intervention: Light physical activity
Number of subjects: 6236
Study 35109470 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-vigorous physical activity (MV PA)
Number of subjects: 6236
Study 33550716 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP) pretreatment before topical anesthetic cream application
Number of subjects: 20
Study 33550716 — intervention group
Group type: COMPARATOR
Intervention: Topical anesthetic cream only (control)
Number of subjects: 20
Study 32054903 — intervention group
Group type: COMPARATOR
Intervention: Bovine lung surfactant applied topically on wounds
Number of subjects: 0
Study 32054903 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 33389549 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazosentan (20 mg/h followed by 60 mg/h continuous infusion)
Number of subjects: 0
Study 33389549 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazosentan (simulated 15 mg/h for 3 hours)
Number of subjects: 0
Study 33389549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33149899 — intervention group
Group type: COMPARATOR
Intervention: Various therapeutic agents tested in adaptive platform trials
Number of subjects: 0
Study 33149899 — intervention group
Group type: COMPARATOR
Intervention: Multi-arm multi-stage (MAMS) trial design
Number of subjects: 0
Study 35848733 — intervention group
Group type: EXPERIMENTAL
Intervention: Porous and BoneMaster (PBM) coated Exceed cup
Number of subjects: 53
Study 35848733 — intervention group
Group type: COMPARATOR
Intervention: Porous-coated (P) Exceed cup
Number of subjects: 53
Study 35848733 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal BMD group
Number of subjects: 53
Study 35848733 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopenia group
Number of subjects: 53
Study 34853395 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin D3
Number of subjects: 0
Study 34853395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33259247 — intervention group
Group type: EXPERIMENTAL
Intervention: CrossFit (n=16)
Number of subjects: 30
Study 33259247 — intervention group
Group type: COMPARATOR
Intervention: Concurrent training (CT) (n=14)
Number of subjects: 30
Study 35255929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stromal cells (MSCs) plus basiliximab and calcineurin inhibitor
Number of subjects: 203
Study 35255929 — intervention group
Group type: COMPARATOR
Intervention: Control group (without MSCs)
Number of subjects: 203
Study 33899447 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex spa treatment with transcranial magnetic therapy (TCMT)
Number of subjects: 122
Study 33899447 — intervention group
Group type: COMPARATOR
Intervention: Identical treatment complex without TCMT (Control)
Number of subjects: 122
Study 33899447 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex spa treatment with TCMT
Number of subjects: 122
Study 34033812 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg daily until delivery
Number of subjects: 20
Study 34033812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32289352 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention offered to participants who consented to an observational cohort study.
Number of subjects: 0
Study 32289352 — intervention group
Group type: COMPARATOR
Intervention: Control group (cohort only) without exercise intervention.
Number of subjects: 0
Study 35795916 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT wisdom enhancement timeline technique
Number of subjects: 6
Study 33321501 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based intervention (IMI) tailored to CBP plus treatment-as-usual (TAU)
Number of subjects: 210
Study 33321501 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based intervention (IMI)
Number of subjects: 210
Study 33321501 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 210
Study 33136049 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental-incisive nerve block (MINB) with finger pressure after inferior alveolar nerve block (IANB)
Number of subjects: 70
Study 33136049 — intervention group
Group type: COMPARATOR
Intervention: Control group received only standard IANB injection of 1.8 mL of 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 70
Study 34620759 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid human milk fortifier (LHMF)
Number of subjects: 158
Study 34620759 — intervention group
Group type: COMPARATOR
Intervention: Powder human milk fortifier (PHMF)
Number of subjects: 158
Study 34959829 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetable-enriched bread (VB)
Number of subjects: 10
Study 34959829 — intervention group
Group type: COMPARATOR
Intervention: Commercial white bread (WB)
Number of subjects: 10
Study 34959829 — intervention group
Group type: COMPARATOR
Intervention: Wheatmeal bread (WMB)
Number of subjects: 10
Study 32295442 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative treatment (Western medicine combined with Jianpi Huatan Tongfu granule)
Number of subjects: 60
Study 32295442 — intervention group
Group type: COMPARATOR
Intervention: Western medical treatment
Number of subjects: 60
Study 32295442 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative treatment
Number of subjects: 60
Study 32295442 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants
Number of subjects: 60
Study 32295442 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with AECOPD
Number of subjects: 60
Study 36219445 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual messages featuring security forces as messengers
Number of subjects: 719
Study 36219445 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual messages with varying messenger occupations and text content
Number of subjects: 719
Study 34018381 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation aromatherapy with Rosa damascena (5 drops of 40% for 20 minutes)
Number of subjects: 98
Study 34018381 — intervention group
Group type: COMPARATOR
Intervention: Control group (inhalation of distilled water)
Number of subjects: 98
Study 34018381 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation aromatherapy with Rosa damascena
Number of subjects: 98
Study 33669520 — intervention group
Group type: EXPERIMENTAL
Intervention: RIS-based channel randomization (RCR) technique
Number of subjects: 0
Study 34656505 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation
Number of subjects: 60
Study 34656505 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 60
Study 34656505 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet plus omega-3 supplementation
Number of subjects: 60
Study 34656505 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 34656505 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study 32767049 — intervention group
Group type: EXPERIMENTAL
Intervention: PK radiomics signatures model (PK model) for 2-class classification task
Number of subjects: 104
Study 32767049 — intervention group
Group type: EXPERIMENTAL
Intervention: PK radiomics signatures model (PK model) for 3-class classification task
Number of subjects: 104
Study 35358592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (subconjunctival 2.5 mg/0.1 ml at surgery and topical 10 mg/ml 4 times per day for 4 weeks)
Number of subjects: 92
Study 35358592 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 92
Study 35358592 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 92
Study 34009444 — intervention group
Group type: EXPERIMENTAL
Intervention: Aktion Glasklar intervention
Number of subjects: 0
Study 34009444 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32348009 — intervention group
Group type: EXPERIMENTAL
Intervention: iRoot BP Plus (experimental group, n=50)
Number of subjects: 110
Study 32348009 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide (control group, n=49)
Number of subjects: 110
Study 34406466 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri Auto ZX2 with OGP kinematics
Number of subjects: 48
Study 34406466 — intervention group
Group type: COMPARATOR
Intervention: Tri Auto ZX2 with continuous rotation
Number of subjects: 48
Study 34406466 — intervention group
Group type: COMPARATOR
Intervention: Root ZX II
Number of subjects: 48
Study 34406466 — intervention group
Group type: COMPARATOR
Intervention: VDW Gold
Number of subjects: 48
Study 34229619 — intervention group
Group type: COMPARATOR
Intervention: Telephone therapist delivered cognitive behavioural therapy (TCBT)
Number of subjects: 0
Study 34229619 — intervention group
Group type: COMPARATOR
Intervention: Web-based cognitive behavioural therapy (WCBT)
Number of subjects: 0
Study 34229619 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 32166564 — intervention group
Group type: EXPERIMENTAL
Intervention: T1-ITM (inorganic trace minerals)
Number of subjects: 648
Study 32166564 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-MIX (half ITMs, half CGMs)
Number of subjects: 648
Study 32166564 — intervention group
Group type: EXPERIMENTAL
Intervention: T3-L-CGMs (50% level of T1)
Number of subjects: 648
Study 32166564 — intervention group
Group type: EXPERIMENTAL
Intervention: T4-M-CGMs (70% level of T1)
Number of subjects: 648
Study 34453878 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based treatments
Number of subjects: 15
Study 32092060 — intervention group
Group type: EXPERIMENTAL
Intervention: ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
Number of subjects: 252
Study 32092060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study 34588210 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinued CGM
Number of subjects: 163
Study 34588210 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued CGM
Number of subjects: 163
Study 34588210 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Discontinued CGM vs Continued CGM
Number of subjects: 163
Study 33022653 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight resistance exercise circuit (CIRC)
Number of subjects: 17
Study 33022653 — intervention group
Group type: COMPARATOR
Intervention: Treadmill-based high-intensity interval exercise (TM)
Number of subjects: 17
Study 35913798 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids (PUFAs) supplementation
Number of subjects: 21
Study 35913798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 35913798 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe in addition to statins
Number of subjects: 21
Study 35913798 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 21
Study 35913798 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs
Number of subjects: 21
Study 36316798 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 0
Study 36316798 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 0
Study 36316798 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (added to eplerenone and amiloride)
Number of subjects: 0
Study 36316798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33635605 — intervention group
Group type: EXPERIMENTAL
Intervention: Resminostat plus S-1
Number of subjects: 101
Study 33635605 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus S-1
Number of subjects: 101
Study 32298501 — intervention group
Group type: COMPARATOR
Intervention: 100% insulin dose
Number of subjects: 26
Study 32298501 — intervention group
Group type: EXPERIMENTAL
Intervention: 130% insulin dose
Number of subjects: 26
Study 32298501 — intervention group
Group type: EXPERIMENTAL
Intervention: 145% insulin dose
Number of subjects: 26
Study 32298501 — intervention group
Group type: EXPERIMENTAL
Intervention: 160% insulin dose
Number of subjects: 26
Study 33575961 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymus thymalin (peptide drug)
Number of subjects: 0
Study 33575961 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study 32702651 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based epilepsy education program (WEEP) for 12 weeks
Number of subjects: 0
Study 32702651 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based epilepsy education program (WEEP) for parents
Number of subjects: 0
Study 33418016 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Balloon Angioplasty (DCB)
Number of subjects: 161
Study 33418016 — intervention group
Group type: COMPARATOR
Intervention: Conventional High-Pressure Balloon Angioplasty (HPB)
Number of subjects: 161
Study 34436635 — intervention group
Group type: COMPARATOR
Intervention: Triathlon PS insert
Number of subjects: 120
Study 34436635 — intervention group
Group type: EXPERIMENTAL
Intervention: Triathlon UC insert
Number of subjects: 120
Study 34436635 — intervention group
Group type: COMPARATOR
Intervention: U2 PS insert
Number of subjects: 120
Study 34436635 — intervention group
Group type: EXPERIMENTAL
Intervention: U2 UC insert
Number of subjects: 120
Study 34085478 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating moxibustion at governor vessel, 2 h per treatment, once a week for 4 weeks
Number of subjects: 90
Study 34085478 — intervention group
Group type: COMPARATOR
Intervention: Momethasone furoate nasal spray, 2 sprays per side per time, once a day for 4 weeks
Number of subjects: 90
Study 33413109 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-assisted eHealth intervention
Number of subjects: 188
Study 33413109 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 188
Study 32976501 — intervention group
Group type: EXPERIMENTAL
Intervention: Worms and Ladders board game
Number of subjects: 372
Study 32976501 — intervention group
Group type: COMPARATOR
Intervention: Snake and Ladder board game (Control)
Number of subjects: 372
Study 34907813 — intervention group
Group type: EXPERIMENTAL
Intervention: mavacamten
Number of subjects: 185
Study 34907813 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 185
Study 32141112 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) - 12 sessions of 20 minutes each, energy/session 4.08 J/cm2, thrice/week
Number of subjects: 54
Study 32141112 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 54
Study 32141112 — intervention group
Group type: COMPARATOR
Intervention: Control group (dietary control and aerobic exercise only)
Number of subjects: 54
Study 32141112 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-contact selective-field radiofrequency (NcRF) - four 30-minute treatments once/week
Number of subjects: 54
Study 36221809 — intervention group
Group type: EXPERIMENTAL
Intervention: Early routine catheter ablation (ER-CA)
Number of subjects: 102
Study 36221809 — intervention group
Group type: COMPARATOR
Intervention: Delayed selective catheter ablation (DS-CA)
Number of subjects: 102
Study 36221809 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 102
Study 33155854 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide sheath (GS) used as an extended working channel (EWC) during TBBx
Number of subjects: 105
Study 34415819 — intervention group
Group type: EXPERIMENTAL
Intervention: dBTi+wearable group (n = 62)
Number of subjects: 128
Study 34415819 — intervention group
Group type: COMPARATOR
Intervention: dBTi group (n = 66)
Number of subjects: 128
Study 33943030 — intervention group
Group type: EXPERIMENTAL
Intervention: HiCommunication intervention
Number of subjects: 5
Study 34932853 — intervention group
Group type: EXPERIMENTAL
Intervention: Home phototherapy
Number of subjects: 147
Study 34932853 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital care
Number of subjects: 147
Study 34210681 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg Q3W plus ipilimumab 50 mg Q6W for 4 doses (PEM200+IPI50)
Number of subjects: 102
Study 34210681 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg Q3W plus ipilimumab 100 mg Q12W for 4 doses (PEM200+IPI100)
Number of subjects: 102
Study 32768871 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dietary phosphorus diet (0.18% available phosphorus content)
Number of subjects: 2
Study 32768871 — intervention group
Group type: COMPARATOR
Intervention: Full mixed diet (control group)
Number of subjects: 2
Study 32768871 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabonomics analysis
Number of subjects: 2
Study 35129010 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluteal trigger point injection (TP)
Number of subjects: 44
Study 35129010 — intervention group
Group type: COMPARATOR
Intervention: Epidural steroid injection (ESI)
Number of subjects: 44
Study 33340443 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin use
Number of subjects: 22500
Study 35415804 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (30-min didactic intervention)
Number of subjects: 104
Study 35415804 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced arm (didactic plus weekly messaging and monetary inducement)
Number of subjects: 104
Study 35415804 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 104
Study 35415804 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced arm
Number of subjects: 104
Study 35415804 — intervention group
Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 104
Study 34934054 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg kg-1) acute
Number of subjects: 14
Study 34934054 — intervention group
Group type: COMPARATOR
Intervention: Placebo (acute)
Number of subjects: 14
Study 36108818 — intervention group
Group type: EXPERIMENTAL
Intervention: LHB sparing
Number of subjects: 194
Study 36108818 — intervention group
Group type: COMPARATOR
Intervention: LHB sectioning
Number of subjects: 194
Study 34777214 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 210
Study 34777214 — intervention group
Group type: COMPARATOR
Intervention: Sham Dry Needling (SDN)
Number of subjects: 210
Study 34777214 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study 33524917 — intervention group
Group type: EXPERIMENTAL
Intervention: Radically open dialectical behavior therapy (RO DBT)
Number of subjects: 13
Study 32956134 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical rehabilitation during the acute hospital stay
Number of subjects: 0
Study 32956134 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical rehabilitation interventions tailored to patient subgroups
Number of subjects: 0
Study 32956134 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary models of service delivery to increase physical activity
Number of subjects: 0
Study 32956134 — intervention group
Group type: COMPARATOR
Intervention: Physical rehabilitation
Number of subjects: 0
Study 34228856 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (Group P)
Number of subjects: 59
Study 34228856 — intervention group
Group type: COMPARATOR
Intervention: Desflurane (Group D)
Number of subjects: 59
Study 32096258 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant surgical ablation of atrial fibrillation during CABG and valve surgery
Number of subjects: 0
Study 32096258 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial appendage closure during AF ablation
Number of subjects: 0
Study 35695996 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) with usual care
Number of subjects: 149
Study 35695996 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 149
Study 35695996 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 149
Study 32520316 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% THC flower
Number of subjects: 121
Study 32520316 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% THC flower
Number of subjects: 121
Study 32520316 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% THC concentrate
Number of subjects: 121
Study 32520316 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% THC concentrate
Number of subjects: 121
Study 32520316 — intervention group
Group type: COMPARATOR
Intervention: Concentrate users vs Flower users
Number of subjects: 121
Study 32520316 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term cannabis consumption
Number of subjects: 121
Study 34613575 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antithrombotic therapy (TAT)
Number of subjects: 83
Study 34613575 — intervention group
Group type: COMPARATOR
Intervention: Dual antithrombotic therapy (DAT)
Number of subjects: 83
Study 34613575 — intervention group
Group type: EXPERIMENTAL
Intervention: Matched cohort of TAT
Number of subjects: 83
Study 34613575 — intervention group
Group type: COMPARATOR
Intervention: Matched cohort of DAT
Number of subjects: 83
Study 33963873 — intervention group
Group type: EXPERIMENTAL
Intervention: UPLIFT (telephone-based depression self-management program)
Number of subjects: 72
Study 33963873 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 72
Study 35137493 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal naloxone (1.4 mg/0.1 mL)
Number of subjects: 201
Study 35137493 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular naloxone (0.8 mg/2 mL)
Number of subjects: 201